BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang W, Feng Z, Rao S, Xiao C, Xue X, Lin Z, Zhang Q, Qi W. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69:1141-1143. [PMID: 32102928 DOI: 10.1136/gutjnl-2020-320832] [Cited by in Crossref: 177] [Cited by in F6Publishing: 177] [Article Influence: 88.5] [Reference Citation Analysis]
Number Citing Articles
1 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hua S, Yang Y, Zou D, Li J, Yan K, Xu Y, Jiang X, Rong X, Ye D. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed Pharmacother 2021;140:111685. [PMID: 34015585 DOI: 10.1016/j.biopha.2021.111685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zarei M, Rahimi K, Hassanzadeh K, Abdi M, Hosseini V, Fathi A, Kakaei K. From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic. Environ Res 2021;201:111555. [PMID: 34197816 DOI: 10.1016/j.envres.2021.111555] [Reference Citation Analysis]
4 Campione E, Cosio T, Rosa L, Lanna C, Di Girolamo S, Gaziano R, Valenti P, Bianchi L. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation. Int J Mol Sci 2020;21:E4903. [PMID: 32664543 DOI: 10.3390/ijms21144903] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
5 Estevinho MM, Magro F. The Impact of SARS-CoV-2 on Inflammatory Bowel Disease. GE Port J Gastroenterol 2020;27:227-9. [PMID: 32775543 DOI: 10.1159/000508114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Trottein F, Sokol H. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Rep 2020;32:107915. [PMID: 32649864 DOI: 10.1016/j.celrep.2020.107915] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 27.5] [Reference Citation Analysis]
7 Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. SARS-CoV-2 and the Gastrointestinal Tract in Children. Front Pediatr 2021;9:617980. [PMID: 33692973 DOI: 10.3389/fped.2021.617980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dallan C, Romano F, Siebert J, Politi S, Lacroix L, Sahyoun C. Septic shock presentation in adolescents with COVID-19. Lancet Child Adolesc Health 2020;4:e21-3. [PMID: 32442421 DOI: 10.1016/S2352-4642(20)30164-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
9 Yun H, Sun Z, Wu J, Tang A, Hu M, Xiang Z. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients. Clin Chim Acta 2020;507:94-7. [PMID: 32315614 DOI: 10.1016/j.cca.2020.04.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 18.0] [Reference Citation Analysis]
10 Kase Y, Okano H. Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders. Inflamm Regen 2020;40:32. [PMID: 32934757 DOI: 10.1186/s41232-020-00143-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Vanella G, Capurso G, Burti C, Fanti L, Ricciardiello L, Souza Lino A, Boskoski I, Bronswijk M, Tyberg A, Krishna Kumar Nair G, Angeletti S, Mauro A, Zingone F, Oppong KW, de la Iglesia-Garcia D, Pouillon L, Papanikolaou IS, Fracasso P, Ciceri F, Rovere-Querini P, Tomba C, Viale E, Eusebi LH, Riccioni ME, van der Merwe S, Shahid H, Sarkar A, Yoo JWG, Dilaghi E, Speight RA, Azzolini F, Buttitta F, Porcari S, Petrone MC, Iglesias-Garcia J, Savarino EV, Di Sabatino A, Di Giulio E, Farrell JJ, Kahaleh M, Roelandt P, Costamagna G, Artifon ELA, Bazzoli F, Testoni PA, Greco S, Arcidiacono PG. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol 2021;8:e000578. [PMID: 33627313 DOI: 10.1136/bmjgast-2020-000578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang F, Qu M, Zhou X, Zhao K, Lai C, Tang Q, Xian W, Chen R, Li X, Li Z, He Q, Liu L. The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China. J Transl Med 2020;18:270. [PMID: 32620125 DOI: 10.1186/s12967-020-02423-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
13 Cordeiro A, Ribamar A, Ramalho A. ADIPOSE TISSUE DYSFUNCTION AND MAFLD IN OBESITY ON THE SCENE OF COVID-19. Clin Res Hepatol Gastroenterol 2021;:101807. [PMID: 34543756 DOI: 10.1016/j.clinre.2021.101807] [Reference Citation Analysis]
14 Yang TY, Li YC, Wang SC, Dai QQ, Jiang XS, Zuo S, Jia L, Zheng JB, Wang HL. Clinical characteristics of patients with COVID-19 presenting with gastrointestinal symptoms as initial symptoms: Retrospective case series. World J Clin Cases 2020; 8(14): 2950-2958 [PMID: 32775377 DOI: 10.12998/wjcc.v8.i14.2950] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Engin AB, Engin ED, Engin A. Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection. Environ Toxicol Pharmacol 2020;79:103436. [PMID: 32562764 DOI: 10.1016/j.etap.2020.103436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
16 D'Ovidio V, Lucidi C, Bruno G, Lisi D, Miglioresi L, Bazuro ME. Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program. Clin Colorectal Cancer 2021;20:e5-e11. [PMID: 32868231 DOI: 10.1016/j.clcc.2020.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
17 Dong Y, Dai T, Liu J, Zhang L, Zhou F. Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2. Adv Sci (Weinh) 2020;:2001474. [PMID: 32837848 DOI: 10.1002/advs.202001474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Nashiry MA, Sumi SS, Sharif Shohan MU, Alyami SA, Azad AKM, Moni MA. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders. Brief Bioinform 2021:bbab126. [PMID: 33993223 DOI: 10.1093/bib/bbab126] [Reference Citation Analysis]
19 Mazzarelli A, Giancola ML, Farina A, Marchioni L, Rueca M, Gruber CEM, Bartolini B, Ascoli Bartoli T, Maffongelli G, Capobianchi MR, Ippolito G, Di Caro A, Nicastri E, Pazienza V; INMI COVID-19 study group. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19. PLoS One 2021;16:e0247041. [PMID: 33596245 DOI: 10.1371/journal.pone.0247041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Meredith J, Khedim CA, Henderson P, Wilson DC, Russell RK. Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease. J Crohns Colitis 2021;15:687-91. [PMID: 32997749 DOI: 10.1093/ecco-jcc/jjaa201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, Iacucci M, Ng SC, Ghosh S, Mao R, Liang J. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Therap Adv Gastroenterol 2020;13:1756284820934626. [PMID: 32595762 DOI: 10.1177/1756284820934626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
22 Ferreira-Silva J, Peixoto A, Rodrigues-Pinto E, Macedo G. Implications of COVID-19 for the busy gastroenterologist. Eur J Gastroenterol Hepatol 2021;33:319-24. [PMID: 32501876 DOI: 10.1097/MEG.0000000000001811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
24 Liu J, Cui M, Yang T, Yao P. Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis. BMJ Open Gastroenterol 2020;7:e000437. [PMID: 32665397 DOI: 10.1136/bmjgast-2020-000437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Liu F, Ye S, Zhu X, He X, Wang S, Li Y, Lin J, Wang J, Lin Y, Ren X, Li Y, Deng Z. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep 2021;15:60. [PMID: 33557941 DOI: 10.1186/s13256-020-02583-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
26 Zhao ZH, Zhou Y, Li WH, Huang QS, Tang ZH, Li H. Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "The Diagnosis and Treatment Program for Coronavirus Disease-2019" from Chinese Authority. Am J Chin Med 2020;48:1035-49. [PMID: 32668970 DOI: 10.1142/S0192415X20500500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
27 Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. bioRxiv 2020:2020. [PMID: 32511375 DOI: 10.1101/2020.05.08.084806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 8.5] [Reference Citation Analysis]
28 Smyk W, Janik MK, Portincasa P, Milkiewicz P, Lammert F, Krawczyk M. COVID-19: Focus on the lungs but do not forget the gastrointestinal tract. Eur J Clin Invest. 2020;50:e13276. [PMID: 32406522 DOI: 10.1111/eci.13276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
29 Turk C, Turk S, Temirci ES, Malkan UY, Haznedaroglu İC. In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320928872. [PMID: 32490715 DOI: 10.1177/1470320320928872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
30 Katz-Agranov N, Zandman-Goddard G. Autoimmunity and COVID-19 - The microbiotal connection. Autoimmun Rev 2021;20:102865. [PMID: 34118455 DOI: 10.1016/j.autrev.2021.102865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Wang JG, Cui HR, Tang HB, Deng XL. Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: a systematic review and meta-analysis. Sci Rep 2020;10:17846. [PMID: 33082472 DOI: 10.1038/s41598-020-74913-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
32 Tao W, Wang X, Zhang G, Guo M, Ma H, Zhao D, Sun Y, He J, Liu L, Zhang K, Wang Y, Weng J, Ma X, Jin T, Zhu S. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell 2021;12:230-5. [PMID: 32978728 DOI: 10.1007/s13238-020-00778-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
33 Søreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai PBS, Otero J, Callegaro D, Warner SG, Baxter NN, Teh CSC, Ng-Kamstra J, Meara JG, Hagander L, Lorenzon L. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg 2020;107:1250-61. [PMID: 32350857 DOI: 10.1002/bjs.11670] [Cited by in Crossref: 265] [Cited by in F6Publishing: 215] [Article Influence: 132.5] [Reference Citation Analysis]
34 Zhao N, Wu L, Cheng Y, Zheng H, Hu P, Hu C, Chen D, Xu P, Chen Q, Cheng P, Chen J, Zhao G. The effect of emergency surgery on acute abdomen patients with COVID-19 pneumonia: a retrospective observational study. Aging (Albany NY) 2020;12:15771-83. [PMID: 32805726 DOI: 10.18632/aging.103839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Yu Y, Chen P. Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review. Front Pediatr 2020;8:287. [PMID: 32574286 DOI: 10.3389/fped.2020.00287] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
36 Ilie OD, Cojocariu RO, Ciobica A, Timofte SI, Mavroudis I, Doroftei B. Forecasting the Spreading of COVID-19 across Nine Countries from Europe, Asia, and the American Continents Using the ARIMA Models. Microorganisms 2020;8:E1158. [PMID: 32751609 DOI: 10.3390/microorganisms8081158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
37 Andrews PLR, Cai W, Rudd JA, Sanger GJ. COVID-19, nausea, and vomiting. J Gastroenterol Hepatol. 2021;36:646-656. [PMID: 32955126 DOI: 10.1111/jgh.15261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
38 Kurian SJ, Unnikrishnan MK, Miraj SS, Bagchi D, Banerjee M, Reddy BS, Rodrigues GS, Manu MK, Saravu K, Mukhopadhyay C, Rao M. Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects. Arch Med Res 2021;52:582-94. [PMID: 33785208 DOI: 10.1016/j.arcmed.2021.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Uzzan M, Soudan D, Peoc'h K, Weiss E, Corcos O, Treton X. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms. Dig Liver Dis 2020;52:1104-5. [PMID: 32646736 DOI: 10.1016/j.dld.2020.06.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
40 Cai T, Mao G, Zheng R, Fang M, Yang X, Wang L, Qi C. Testicular injury during SARS-CoV-2 infection may be neglected: An assessment from scRNA-seq profiling and protein detection of angiotensin-converting enzyme II. Exp Ther Med 2021;22:1485. [PMID: 34765026 DOI: 10.3892/etm.2021.10920] [Reference Citation Analysis]
41 Li H, Liu Z, Ge J. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. J Cell Mol Med 2020;24:6558-70. [PMID: 32320516 DOI: 10.1111/jcmm.15364] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
42 Zhao B, Wei Y, Sun W, Qin C, Zhou X, Wang Z, Li T, Cao H, Wang Y, Wang W. Distinguishing Coronavirus Disease 2019 Patients From General Surgery Emergency Patients With the CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China. Front Med (Lausanne) 2021;8:601941. [PMID: 33996842 DOI: 10.3389/fmed.2021.601941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Gupta S, Mitra A. Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2. Heart Fail Rev 2021. [PMID: 33426593 DOI: 10.1007/s10741-021-10076-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, Jain R. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021;21:177-80. [PMID: 34239378 DOI: 10.31486/toj.20.0086] [Reference Citation Analysis]
45 Qian Q, Fan L, Liu W, Li J, Yue J, Wang M, Ke X, Yin Y, Chen Q, Jiang C. Direct evidence of active SARS-CoV-2 replication in the intestine. Clin Infect Dis. 2020;. [PMID: 32638022 DOI: 10.1093/cid/ciaa925] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 38.0] [Reference Citation Analysis]
46 Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol 2021;93:1387-95. [PMID: 33150973 DOI: 10.1002/jmv.26653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
47 Barbuddhe SB, Rawool DB, Gaonkar PP, Vergis J, Dhama K, Malik SS. Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic. Hum Vaccin Immunother 2020;16:3023-33. [PMID: 33121328 DOI: 10.1080/21645515.2020.1810496] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Wang F, Zheng S, Zheng C, Sun X. Attaching clinical significance to COVID-19-associated diarrhea. Life Sci 2020;260:118312. [PMID: 32846165 DOI: 10.1016/j.lfs.2020.118312] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
49 Kumar M, Mazumder P, Mohapatra S, Kumar Thakur A, Dhangar K, Taki K, Mukherjee S, Kumar Patel A, Bhattacharya P, Mohapatra P, Rinklebe J, Kitajima M, Hai FI, Khursheed A, Furumai H, Sonne C, Kuroda K. A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance. J Hazard Mater 2021;405:124043. [PMID: 33268203 DOI: 10.1016/j.jhazmat.2020.124043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
50 Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F. COVID-19 and cutaneous manifestations: a systematic review. J Eur Acad Dermatol Venereol. 2020;34:2505-2510. [PMID: 32594572 DOI: 10.1111/jdv.16778] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
51 Keuchel M, Bota M, Baltes P. Infectious diseases affecting the small bowel - what not to miss. Curr Opin Gastroenterol 2021;37:255-66. [PMID: 33769379 DOI: 10.1097/MOG.0000000000000720] [Reference Citation Analysis]
52 Uzzan M, Corcos O, Martin JC, Treton X, Bouhnik Y. Why is SARS-CoV-2 infection more severe in obese men? Med Hypotheses. 2020;144:110023. [PMID: 32593832 DOI: 10.1016/j.mehy.2020.110023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
53 Funt SA, Cohen SL, Wang JJ, Sanelli PC, Barish MA. Abdominal pelvic CT findings compared between COVID-19 positive and COVID-19 negative patients in the emergency department setting. Abdom Radiol (NY). 2021;46:1498-1505. [PMID: 33044654 DOI: 10.1007/s00261-020-02796-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Mohapatra RK, Dhama K, Mishra S, Sarangi AK, Kandi V, Tiwari R, Pintilie L. The microbiota-related coinfections in COVID-19 patients: a real challenge. Beni Suef Univ J Basic Appl Sci 2021;10:47. [PMID: 34458380 DOI: 10.1186/s43088-021-00134-7] [Reference Citation Analysis]
55 Luo J, Liang S, Jin F. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19. Sci China Life Sci 2021;64:942-56. [PMID: 33521857 DOI: 10.1007/s11427-020-1847-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
56 Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg 2021:trab042. [PMID: 33728439 DOI: 10.1093/trstmh/trab042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Aslan AT, Şimşek H. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations. Euroasian J Hepatogastroenterol 2021;11:81-6. [PMID: 34786361 DOI: 10.5005/jp-journals-10018-1347] [Reference Citation Analysis]
58 Sun JK, Liu Y, Zou L, Zhang WH, Li JJ, Wang Y, Kan XH, Chen JD, Shi QK, Yuan ST. Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China. World J Gastroenterol 2020; 26(39): 6087-6097 [PMID: 33132657 DOI: 10.3748/wjg.v26.i39.6087] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
59 Duan J, Liang M, Li Y, Wu D, Chen Y, Gao S, Jia P, Yang M, Xia W, Wu X, Li Q, Zuo F, Zhang Y, He Y, Nie J, Zhou W, Fu X, Peng X, Ma Z, Fu X, Zeng L, You W, Fang Y, Zhu L, Liu P. Definition and retrospective application of a clinical scoring system for COVID-19 triage at presentation. Ther Adv Respir Dis 2020;14:1753466620963019. [PMID: 33054697 DOI: 10.1177/1753466620963019] [Reference Citation Analysis]
60 Zhang Q, Yue S, Wang W, Chen Y, Zhao C, Song Y, Yan D, Zhang L, Tang Y. Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19. Am J Chin Med 2021;49:785-803. [PMID: 33853498 DOI: 10.1142/S0192415X21500373] [Reference Citation Analysis]
61 Cevik M, Bamford CGG, Ho A. COVID-19 pandemic-a focused review for clinicians. Clin Microbiol Infect 2020;26:842-7. [PMID: 32344166 DOI: 10.1016/j.cmi.2020.04.023] [Cited by in Crossref: 156] [Cited by in F6Publishing: 131] [Article Influence: 78.0] [Reference Citation Analysis]
62 Yang X, Zhao J, Yan Q, Zhang S, Wang Y, Li Y. A case of COVID-19 patient with the diarrhea as initial symptom and literature review. Clin Res Hepatol Gastroenterol. 2020;44:e109-e112. [PMID: 32305249 DOI: 10.1016/j.clinre.2020.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
63 Nicolau LAD, Nolêto IRSG, Medeiros JVR. Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight. Expert Rev Clin Pharmacol 2020;13:807-11. [PMID: 32686527 DOI: 10.1080/17512433.2020.1798760] [Reference Citation Analysis]
64 Thakur V, Ratho RK, Kumar P, Bhatia SK, Bora I, Mohi GK, Saxena SK, Devi M, Yadav D, Mehariya S. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. J Clin Med 2021;10:446. [PMID: 33498861 DOI: 10.3390/jcm10030446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
65 Yang Q, Yang X. Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients. PLoS One 2020;15:e0241953. [PMID: 33196669 DOI: 10.1371/journal.pone.0241953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
66 Mourmouris P, Tzelves L, Roidi C, Fotsali A. COVID-19 transmission: a rapid systematic review of current knowledge. Osong Public Health Res Perspect 2021;12:54-63. [PMID: 33979995 DOI: 10.24171/j.phrp.2021.12.2.02] [Reference Citation Analysis]
67 Doroftei B, Ilie OD, Cojocariu RO, Ciobica A, Maftei R, Grab D, Anton E, McKenna J, Dhunna N, Simionescu G. Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects. Molecules 2020;25:E3323. [PMID: 32707945 DOI: 10.3390/molecules25153323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
68 Ghoshal UC, Ghoshal U, Dhiman RK. Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. J Clin Exp Hepatol 2020;10:622-8. [PMID: 32837095 DOI: 10.1016/j.jceh.2020.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
69 Laszkowska M, Faye AS, Kim J, Truong H, Silver ER, Ingram M, May B, Ascherman B, Bartram L, Zucker J, Sobieszczyk ME, Abrams JA, Lebwohl B, Freedberg DE, Hur C. Disease Course and Outcomes of COVID-19 Among Hospitalized Patients With Gastrointestinal Manifestations. Clin Gastroenterol Hepatol 2021;19:1402-1409.e1. [PMID: 33007514 DOI: 10.1016/j.cgh.2020.09.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
70 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
71 de Oliveira AP, Lopes ALF, Pacheco G, de Sá Guimarães Nolêto IR, Nicolau LAD, Medeiros JVR. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route. Med Hypotheses 2020;144:110243. [PMID: 33254549 DOI: 10.1016/j.mehy.2020.110243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
72 Liu J, Yu C, Yang Q, Yuan X, Yang F, Li P, Chen G, Liang W, Yang Y. The clinical implication of gamma-glutamyl transpeptidase in COVID-19. Liver Res 2021. [PMID: 34603826 DOI: 10.1016/j.livres.2021.09.001] [Reference Citation Analysis]
73 Singh M, Bansal V, Feschotte C. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. SSRN 2020;:3611279. [PMID: 32714119 DOI: 10.2139/ssrn.3611279] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Wang N, Qin L, Ma L, Yan H. Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system. Stem Cell Res 2021;52:102189. [PMID: 33582547 DOI: 10.1016/j.scr.2021.102189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
76 Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, Yip CCY, Leung KH, Fung AY, Zhang RR, Lin Y, Cheng HM, Zhang AJX, To KKW, Chan KH, Yuen KY, Leung WK. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020;159:81-95. [PMID: 32251668 DOI: 10.1053/j.gastro.2020.03.065] [Cited by in Crossref: 539] [Cited by in F6Publishing: 516] [Article Influence: 269.5] [Reference Citation Analysis]
77 Gornet JM, Tran Minh ML, Leleu F, Hassid D. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19? J Visc Surg 2020;157:S51-7. [PMID: 32360205 DOI: 10.1016/j.jviscsurg.2020.04.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
78 Hawryłkowicz V, Lietz-Kijak D, Kaźmierczak-Siedlecka K, Sołek-Pastuszka J, Stachowska L, Folwarski M, Parczewski M, Stachowska E. Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021? Nutrients 2021;13:3385. [PMID: 34684384 DOI: 10.3390/nu13103385] [Reference Citation Analysis]
79 Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, Ali N, Gang W, Qian G, Ullah R, Shah T, Ullah M, Khan I, Nisar MF, Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021;133:110947. [PMID: 33197765 DOI: 10.1016/j.biopha.2020.110947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
80 Gornet JM, Tran Minh ML, Leleu F, Hassid D. [What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?]. J Chir Visc 2020;157:S52-9. [PMID: 32341722 DOI: 10.1016/j.jchirv.2020.04.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Ben S, Xin J, Chen S, Jiang Y, Yuan Q, Su L, Christiani DC, Zhang Z, Du M, Wang M. Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks. J Infect 2021:S0163-4453(21)00546-6. [PMID: 34767837 DOI: 10.1016/j.jinf.2021.11.003] [Reference Citation Analysis]
82 Du L, Cao X, Chen J, Wei X, Zeng Y, Cheng C, Lin Y, Tan W, Wang H. Fecal occult blood and urinary cytology tests for rapid screening of inflammatory infection in the gastrointestinal and urological systems in patients with Coronavirus disease 2019. J Clin Lab Anal 2021;35:e23626. [PMID: 33063366 DOI: 10.1002/jcla.23626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
83 Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis. Indian J Gastroenterol 2020;39:268-84. [PMID: 32749643 DOI: 10.1007/s12664-020-01058-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
84 Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, Lai CKC, Chen Z, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology 2020;159:944-955.e8. [PMID: 32442562 DOI: 10.1053/j.gastro.2020.05.048] [Cited by in Crossref: 278] [Cited by in F6Publishing: 285] [Article Influence: 139.0] [Reference Citation Analysis]
85 Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, Yuan W, Sun Z. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19. Front Immunol 2021;12:674074. [PMID: 34858386 DOI: 10.3389/fimmu.2021.674074] [Reference Citation Analysis]
86 Suresh V, Parida D, Minz AP, Sethi M, Sahoo BS, Senapati S. Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies. Front Pharmacol 2020;11:579330. [PMID: 33568991 DOI: 10.3389/fphar.2020.579330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Mackett AJ, Keevil VL. COVID-19 and Gastrointestinal Symptoms-A Case Report. Geriatrics (Basel) 2020;5:E31. [PMID: 32429041 DOI: 10.3390/geriatrics5020031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Qin C, Wei Y, Lyu X, Zhao B, Feng Y, Li T, Cao H, Yang X, Zhou X, Wang W, You L, Wang Y. High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients. Sci Rep 2020;10:16496. [PMID: 33020546 DOI: 10.1038/s41598-020-73575-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
89 Brüssow H. The Novel Coronavirus - A Snapshot of Current Knowledge. Microb Biotechnol 2020;13:607-12. [PMID: 32144890 DOI: 10.1111/1751-7915.13557] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
90 Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Bannazadeh Baghi H. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg 2020;103:1783-96. [PMID: 32940201 DOI: 10.4269/ajtmh.20-0986] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
91 Mirmohammadi S, Kianmehr A, Arefi M, Mahrooz A. Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran. New Microbes New Infect 2020;38:100792. [PMID: 33101694 DOI: 10.1016/j.nmni.2020.100792] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Liu C, Wang K, Zhang M, Hu X, Hu T, Liu Y, Hu Q, Wu S, Yue J. High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients. NPJ Precis Oncol 2021;5:1. [PMID: 33479506 DOI: 10.1038/s41698-020-00139-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
93 Lu X, Wang Y, Chen T, Wang J, Yan F. Classification of COVID-19 in intensive care patients. Crit Care 2020;24:399. [PMID: 32646506 DOI: 10.1186/s13054-020-03127-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, Zhang C, Zhao E, Rustgi VK. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations . World J Gastroenterol 2021; 27(46): 7969-7981 [DOI: 10.3748/wjg.v27.i46.7969] [Reference Citation Analysis]
95 Sahai A, Bhandari R, Koupenova M, Freedman J, Godwin M, McIntyre T, Chung M, Iskandar JP, Kamran H, Aggarwal A, Kalra A, Bartholomew J, McCrae K, Elbadawi A, Svensson L, Kapadia S, Hariri E, Cameron S. SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients. Res Sq 2020:rs. [PMID: 33398263 DOI: 10.21203/rs.3.rs-119031/v1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
96 Nie K, Yang YY, Deng MZ, Wang XY. Gastrointestinal insights during the COVID-19 epidemic. World J Clin Cases 2020; 8(18): 3934-3941 [PMID: 33024750 DOI: 10.12998/wjcc.v8.i18.3934] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
97 Lee IC, Huo TI, Huang YH. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc 2020;83:521-3. [PMID: 32243269 DOI: 10.1097/JCMA.0000000000000319] [Cited by in Crossref: 66] [Cited by in F6Publishing: 41] [Article Influence: 33.0] [Reference Citation Analysis]
98 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
99 Dhar J, Samanta J, Kochhar R. Corona Virus Disease-19 pandemic: The gastroenterologists' perspective. Indian J Gastroenterol. 2020;39:220-231. [PMID: 32783168 DOI: 10.1007/s12664-020-01075-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
100 Li C, He Q, Qian H, Liu J. Overview of the pathogenesis of COVID-19 (Review). Exp Ther Med 2021;22:1011. [PMID: 34345293 DOI: 10.3892/etm.2021.10444] [Reference Citation Analysis]
101 Ahmed M, Ahmed MH. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases 2021; 9(17): 4133-4142 [PMID: 34141776 DOI: 10.12998/wjcc.v9.i17.4133] [Reference Citation Analysis]
102 Lamadrid P, Alonso-Peña M, San Segundo D, Arias-Loste M, Crespo J, Lopez-Hoyos M. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. Front Immunol 2021;12:651728. [PMID: 33859644 DOI: 10.3389/fimmu.2021.651728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Lee S, Yoon GY, Myoung J, Kim SJ, Ahn DG. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg Microbes Infect 2020;9:2169-79. [PMID: 32969768 DOI: 10.1080/22221751.2020.1827985] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
104 Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol 2020;44:265-72. [PMID: 32595361 DOI: 10.3906/biy-2005-102] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
105 DosSantos MF, Devalle S, Aran V, Capra D, Roque NR, Coelho-Aguiar JM, Spohr TCLSE, Subilhaga JG, Pereira CM, D'Andrea Meira I, Niemeyer Soares Filho P, Moura-Neto V. Neuromechanisms of SARS-CoV-2: A Review. Front Neuroanat 2020;14:37. [PMID: 32612515 DOI: 10.3389/fnana.2020.00037] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 23.0] [Reference Citation Analysis]
106 Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? Arab J Gastroenterol. 2020;21:3-8. [PMID: 32253172 DOI: 10.1016/j.ajg.2020.03.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 29.0] [Reference Citation Analysis]
107 Guo G, Ye L, Pan K, Chen Y, Xing D, Yan K, Chen Z, Ding N, Li W, Huang H, Zhang L, Li X, Xue X. New insights of emerging SARS-CoV-2: Epidemiology, etiology, clinical features, clinical treatment, and prevention. Front Cell Dev Biol. 2020;8:410. [PMID: 32574318 DOI: 10.3389/fcell.2020.00410] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
108 Zuo T, Liu Q, Zhang F, Lui GC, Tso EY, Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK, Ng SC. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 2021;70:276-84. [PMID: 32690600 DOI: 10.1136/gutjnl-2020-322294] [Cited by in Crossref: 68] [Cited by in F6Publishing: 98] [Article Influence: 34.0] [Reference Citation Analysis]
109 Gupta R, Misra A. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab Syndr. 2020;14:251-254. [PMID: 32247213 DOI: 10.1016/j.dsx.2020.03.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 28.0] [Reference Citation Analysis]
110 Zarifian A, Zamiri Bidary M, Arekhi S, Rafiee M, Gholamalizadeh H, Amiriani A, Ghaderi MS, Khadem-Rezaiyan M, Amini M, Ganji A. Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: A systematic review and meta-analysis. J Med Virol 2021;93:336-50. [PMID: 32681674 DOI: 10.1002/jmv.26314] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
111 Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F. High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2. J Invest Dermatol 2021;141:206-209.e1. [PMID: 32454066 DOI: 10.1016/j.jid.2020.05.087] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
112 Simsek C, Erul E, Balaban HY. Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2. World J Clin Cases 2021; 9(20): 5427-5434 [PMID: 34307596 DOI: 10.12998/wjcc.v9.i20.5427] [Reference Citation Analysis]
113 Panayi AC, Kauke M, Pomahac B. COVID-19 in a Face Transplant Patient. Transplantation 2021;105:e96-8. [PMID: 33901110 DOI: 10.1097/TP.0000000000003789] [Reference Citation Analysis]
114 Liu J, Tao L, Liu X, Yao H, Yu S, Wang Q, Zhang J, Gao Z, Jiang R, Jing W, Liu M. GI symptoms and fever increase the risk of severe illness and death in patients with COVID-19. Gut 2021;70:442-4. [PMID: 32606209 DOI: 10.1136/gutjnl-2020-321751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Wang Q, Liu L. On the Critical Role of Human Feces and Public Toilets in the Transmission of COVID-19: Evidence from China. Sustain Cities Soc 2021;75:103350. [PMID: 34540563 DOI: 10.1016/j.scs.2021.103350] [Reference Citation Analysis]
116 Dipasquale V, Passanisi S, Cucinotta U, Cascio A, Romano C. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital J Pediatr 2021;47:71. [PMID: 33761992 DOI: 10.1186/s13052-021-01020-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Agarwal A, Chen A, Ravindran N, To C, Thuluvath PJ. Gastrointestinal and Liver Manifestations of COVID-19. J Clin Exp Hepatol. 2020;10:263-265. [PMID: 32405183 DOI: 10.1016/j.jceh.2020.03.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 19.5] [Reference Citation Analysis]
118 Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, Lyu J, Dai ZM. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020;96:19-24. [PMID: 32311451 DOI: 10.1016/j.ijid.2020.04.027] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 49.5] [Reference Citation Analysis]
119 Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut 2020;69:973-4. [PMID: 32273292 DOI: 10.1136/gutjnl-2020-321195] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 45.0] [Reference Citation Analysis]
120 Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, Ahmad F, Muronetz V, Samy Abousenna M, Zolghadri S, Saboury AA. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med 2021;10:4802. [PMID: 34768321 DOI: 10.3390/jcm10214802] [Reference Citation Analysis]
121 Miller J, Yan KS. COVID-19 Gastrointestinal Symptoms and Attenuation of the Immune Response to SARS-CoV-2. Gastroenterology 2021;160:2251-4. [PMID: 33753106 DOI: 10.1053/j.gastro.2021.03.029] [Reference Citation Analysis]
122 Zhang M, Feng C, Zhang X, Hu S, Zhang Y, Min M, Liu B, Ying X, Liu Y. Susceptibility Factors of Stomach for SARS-CoV-2 and Treatment Implication of Mucosal Protective Agent in COVID-19. Front Med (Lausanne). 2020;7:597967. [PMID: 33521016 DOI: 10.3389/fmed.2020.597967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Jesus MCS, Lima AGA, Santos VS, Storti-Melo LM, Moura TR, Santos RWFD, Santos CAD, Martins-Filho PR, Cuevas LE, Gurgel RQ. Family COVID-19 cluster analysis of an infant without respiratory symptoms. Rev Soc Bras Med Trop 2020;53:e20200494. [PMID: 32876320 DOI: 10.1590/0037-8682-0494-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Mirashrafi S, Moravejolahkami AR, Balouch Zehi Z, Hojjati Kermani MA, Bahreini-Esfahani N, Haratian M, Ganjali Dashti M, Pourhossein M. The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment. Clin Nutr ESPEN 2021;46:1-8. [PMID: 34857182 DOI: 10.1016/j.clnesp.2021.10.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Giuffrè M, Di Bella S, Sambataro G, Zerbato V, Cavallaro M, Occhipinti AA, Palermo A, Crescenti A, Monica F, Luzzati R, Crocè LS. COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19. Trop Med Infect Dis 2020;5:E147. [PMID: 32947803 DOI: 10.3390/tropicalmed5030147] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
126 de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front Immunol 2021;12:635471. [PMID: 33717181 DOI: 10.3389/fimmu.2021.635471] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
127 Silva FAFD, de Brito BB, Santos MLC, Marques HS, da Silva Júnior RT, de Carvalho LS, de Sousa Cruz S, Rocha GR, Correa Santos GL, de Souza KC, Maciel RGA, Lopes DS, Silva NOE, Oliveira MV, de Melo FF. Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge. World J Clin Cases 2021; 9(28): 8280-8294 [PMID: 34754839 DOI: 10.12998/wjcc.v9.i28.8280] [Reference Citation Analysis]
128 Ong J, Young BE, Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;69:1144-1145. [PMID: 32198152 DOI: 10.1136/gutjnl-2020-321051] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 31.5] [Reference Citation Analysis]
129 Ungaro RC, Sullivan T, Colombel JF, Patel G. What Should Gastroenterologists and Patients Know About COVID-19? Clin Gastroenterol Hepatol. 2020;18:1409-1411. [PMID: 32197957 DOI: 10.1016/j.cgh.2020.03.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
130 Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat 2021;28:4-11. [PMID: 33190321 DOI: 10.1111/jvh.13440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
131 Portincasa P, Krawczyk M, Smyk W, Lammert F, Di Ciaula A. COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. Eur J Clin Invest. 2020;50:e13338. [PMID: 32589264 DOI: 10.1111/eci.13338] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 12.5] [Reference Citation Analysis]
132 Sahai A, Bhandari R, Godwin M, McIntyre T, Chung MK, Iskandar JP, Kamran H, Hariri E, Aggarwal A, Burton R, Kalra A, Bartholomew JR, McCrae KR, Elbadawi A, Bena J, Svensson LG, Kapadia S, Cameron SJ. Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19. Vasc Med 2021;:1358863X211012754. [PMID: 34010070 DOI: 10.1177/1358863X211012754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
133 Liu H, Gai S, Wang X, Zeng J, Sun C, Zhao Y, Zheng Z. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Cardiovasc Res 2020;116:1733-41. [PMID: 32638018 DOI: 10.1093/cvr/cvaa191] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
134 Zuo T, Liu Q, Zhang F, Yeoh YK, Wan Y, Zhan H, Lui GCY, Chen Z, Li AYL, Cheung CP, Chen N, Lv W, Ng RWY, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity. Microbiome 2021;9:91. [PMID: 33853691 DOI: 10.1186/s40168-021-01008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
135 Miyara SJ, Becker LB, Guevara S, Kirsch C, Metz CN, Shoaib M, Grodstein E, Nair VV, Jandovitz N, McCann-Molmenti A, Hayashida K, Takegawa R, Shinozaki K, Yagi T, Aoki T, Nishikimi M, Choudhary RC, Cho YM, Zanos S, Zafeiropoulos S, Hoffman HB, Watt S, Lumermann CM, Aronsohn J, Shore-Lesserson L, Molmenti EP. Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York. Front Med (Lausanne) 2021;8:638075. [PMID: 34150792 DOI: 10.3389/fmed.2021.638075] [Reference Citation Analysis]
136 Lian Z, Li Y, Wang W, Ding W, Niu Z, Yang X, Wu C. The Prediction Model of Risk Factors for COVID-19 Developing into Severe Illness Based on 1046 Patients with COVID-19. Emerg Med Int 2021;2021:7711056. [PMID: 34804612 DOI: 10.1155/2021/7711056] [Reference Citation Analysis]
137 Fardoos R, Asowata OE, Herbert N, Nyquist SK, Zungu Y, Singh A, Ngoepe A, Mbano IM, Mthabela N, Ramjit D, Karim F, Kuhn W, Madela FG, Manzini VT, Anderson F, Berger B, Pers TH, Shalek AK, Leslie A, Kløverpris HN. HIV infection drives interferon signaling within intestinal SARS-CoV-2 target cells. JCI Insight 2021;6:148920. [PMID: 34252054 DOI: 10.1172/jci.insight.148920] [Reference Citation Analysis]
138 Abbasinia M, Hormati A, Eshagh Hossaini SK, Foroghi Ghomi SY, Zamani F, Afifian M, Ahmadpour S. Clinical Manifestations of Gastrointestinal Symptoms in COVID-19 Patients: An Integrative Review. Gastroenterol Nurs 2021;44:E1-E10. [PMID: 33538525 DOI: 10.1097/SGA.0000000000000584] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Peng X, Chen Y, Deng L, Liu Q, Li Q, Xiong J, Shi Y, Tang S. Clinical features of critically ill patients infected with SARS-CoV-2 outside Wuhan with and without diabetes. Int J Diabetes Dev Ctries 2020;:1-9. [PMID: 33169053 DOI: 10.1007/s13410-020-00888-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
140 Salamanna F, Maglio M, Landini MP, Fini M. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2. Front Med (Lausanne) 2020;7:594495. [PMID: 33344479 DOI: 10.3389/fmed.2020.594495] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
141 Li XZ, Qiu Y, Jeffery L, Liu F, Feng R, He JS, Tan JY, Ye ZY, Lin SN, Ghosh S, Iacucci M, Chen MH, Mao R. Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19. Front Med (Lausanne) 2020;7:613475. [PMID: 33511147 DOI: 10.3389/fmed.2020.613475] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol 2020;5:598-606. [PMID: 32305075 DOI: 10.1016/S2468-1253(20)30119-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 21.0] [Reference Citation Analysis]
143 Deidda S, Tora L, Firinu D, Del Giacco S, Campagna M, Meloni F, Orrù G, Chessa L, Carta MG, Melis A, Spolverato G, Littera R, Perra A, Onali S, Zorcolo L, Restivo A. Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management. Expert Review of Gastroenterology & Hepatology 2021;15:41-50. [DOI: 10.1080/17474124.2020.1821653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
144 Zuo T, Wu X, Wen W, Lan P. Gut Microbiome Alterations in COVID-19. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00206-0. [PMID: 34560321 DOI: 10.1016/j.gpb.2021.09.004] [Reference Citation Analysis]
145 Guo Y, Wang B, Gao H, Gao L, Hua R, Xu JD. ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology. Front Mol Biosci 2021;8:708336. [PMID: 34631794 DOI: 10.3389/fmolb.2021.708336] [Reference Citation Analysis]
146 Zhang Y, Geng X, Tan Y, Li Q, Xu C, Xu J, Hao L, Zeng Z, Luo X, Liu F, Wang H. New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomed Pharmacother. 2020;127:110195. [PMID: 32361161 DOI: 10.1016/j.biopha.2020.110195] [Cited by in Crossref: 95] [Cited by in F6Publishing: 74] [Article Influence: 47.5] [Reference Citation Analysis]
147 Hayee B, Thoufeeq M, Rees CJ, Penman I, East J. Safely restarting GI endoscopy in the era of COVID-19. Gut 2020;69:2063-70. [DOI: 10.1136/gutjnl-2020-321688] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
148 Vaselli NM, Setiabudi W, Subramaniam K, Adams ER, Turtle L, Iturriza-Gómara M, Solomon T, Cunliffe NA, French N, Hungerford D; COVID-LIV Study Group. Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK. BMC Infect Dis 2021;21:784. [PMID: 34372788 DOI: 10.1186/s12879-021-06443-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H. Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:431. [PMID: 32793616 DOI: 10.3389/fmed.2020.00431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
150 Sultan K, Mone A, Durbin L, Khuwaja S, Swaminath A. Review of inflammatory bowel disease and COVID-19. World J Gastroenterol 2020; 26(37): 5534-5542 [PMID: 33088153 DOI: 10.3748/wjg.v26.i37.5534] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
151 Xu Z, Tang M, Chen P, Cai H, Xiao F. SARS-CoV-2 Gastrointestinal Infection Prolongs the Time to Recover From COVID-19. Front Med (Lausanne) 2021;8:683551. [PMID: 34150815 DOI: 10.3389/fmed.2021.683551] [Reference Citation Analysis]
152 Wang HG, Xie R, Ma TH, Yang XZ. Excessive anxiety in IBD patients is unnecessary for COVID-19. Clin Res Hepatol Gastroenterol 2020;44:e121-2. [PMID: 32409282 DOI: 10.1016/j.clinre.2020.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
153 Farooq A, Alam F, Saeed A, Butt F, Khaliq MA, Malik A, Chaudhry M, Abdullah M. Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management. Infect Dis (Auckl) 2021;14:11786337211026642. [PMID: 34220204 DOI: 10.1177/11786337211026642] [Reference Citation Analysis]
154 Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N, Viazis N, Liatsos C, Mantzaris GJ. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol 2020; 26(31): 4579-4588 [PMID: 32884218 DOI: 10.3748/wjg.v26.i31.4579] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
155 Poggiali E, Mateo Ramos P, Bastoni D, Vercelli A, Magnacavallo A. Abdominal Pain: A Real Challenge in Novel COVID-19 Infection. Eur J Case Rep Intern Med 2020;7:001632. [PMID: 32309266 DOI: 10.12890/2020_001632] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
156 Wang JG, Zhong ZJ, Li M, Fu J, Su YH, Ping YM, Xu ZJ, Li H, Chen YH, Huang YL. Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis. Biochem Res Int 2021;2021:5596727. [PMID: 34336288 DOI: 10.1155/2021/5596727] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Corrêa Neto IJF, Viana KF, Silva MBSD, Silva LMD, Oliveira GD, Cecchini ARDS, Rolim AS, Robles L. Perforated acute abdomen in a patient with COVID-19: an atypical manifestation of the disease. Journal of Coloproctology 2021;40:269-72. [DOI: 10.1016/j.jcol.2020.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 13.0] [Reference Citation Analysis]
158 Godoy MG, Kibenge MJT, Kibenge FSB. SARS-CoV-2 transmission via aquatic food animal species or their products: A review. Aquaculture 2021;536:736460. [PMID: 33564203 DOI: 10.1016/j.aquaculture.2021.736460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
159 Yang RX, Zheng RD, Fan JG. Etiology and management of liver injury in patients with COVID-19. World J Gastroenterol 2020; 26(32): 4753-4762 [PMID: 32921955 DOI: 10.3748/wjg.v26.i32.4753] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
160 Shehab M, Alrashed F, Shuaibi S, Alajmi D, Barkun A. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol 2021;8:e000571. [PMID: 33664052 DOI: 10.1136/bmjgast-2020-000571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
161 Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020;20:493-506. [PMID: 32720223 DOI: 10.1007/s10238-020-00648-x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 52.5] [Reference Citation Analysis]
162 Peng M. Outbreak of COVID-19: An emerging global pandemic threat. Biomed Pharmacother 2020;129:110499. [PMID: 32768974 DOI: 10.1016/j.biopha.2020.110499] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
163 Vranić L, Radovan A, Poropat G, Mikolašević I, Milić S. Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas) 2021;57:1057. [PMID: 34684094 DOI: 10.3390/medicina57101057] [Reference Citation Analysis]
164 Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G. SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs. Microorganisms 2021;9:793. [PMID: 33920179 DOI: 10.3390/microorganisms9040793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
165 Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, Müller T, Adolph TE, Tilg H. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 2020;69:1543-4. [PMID: 32312790 DOI: 10.1136/gutjnl-2020-321388] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 56.5] [Reference Citation Analysis]
166 Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 [PMID: 34904088 DOI: 10.12998/wjcc.v9.i33.10180] [Reference Citation Analysis]
167 Ramachandran P, Onukogu I, Ghanta S, Gajendran M, Perisetti A, Goyal H, Aggarwal A. Gastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease 2019 Patients. Dig Dis 2020;38:373-9. [PMID: 32599601 DOI: 10.1159/000509774] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
168 Di Sessa A, Lanzaro F, Zarrilli S, Picone V, Guarino S, Miraglia del Giudice E, Marzuillo P. COVID-19 and pediatric fatty liver disease: Is there interplay? World J Gastroenterol 2021; 27(22): 3064-3072 [PMID: 34168408 DOI: 10.3748/wjg.v27.i22.3064] [Reference Citation Analysis]
169 Kabir A, Datta P, Oh J, Williams A, Ozbolat V, Unutmaz D, T Ozbolat I. 3D Bioprinting for fabrication of tissue models of COVID-19 infection. Essays Biochem 2021:EBC20200129. [PMID: 34028514 DOI: 10.1042/EBC20200129] [Reference Citation Analysis]
170 Shi J, Sun J, Hu Y. Enteric involvement of SARS-CoV-2: Implications for the COVID-19 management, transmission, and infection control. Virulence 2020;11:941-4. [PMID: 32715925 DOI: 10.1080/21505594.2020.1794410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
171 Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol 2021; 27(6): 449-469 [PMID: 33642821 DOI: 10.3748/wjg.v27.i6.449] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
172 Nuccetelli M, Pieri M, Gisone F, Bernardini S. Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves. Immunol Invest 2020;:1-13. [PMID: 32945214 DOI: 10.1080/08820139.2020.1823407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
173 Qiu HJ, Yuan LX, Wu QW, Zhou YQ, Zheng R, Huang XK, Yang QT. Using the internet search data to investigate symptom characteristics of COVID-19: A big data study. World J Otorhinolaryngol Head Neck Surg 2020;6:S40-8. [PMID: 32837757 DOI: 10.1016/j.wjorl.2020.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
174 Aliter KF, Al-Horani RA. Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19. Cardiovasc Drugs Ther 2021;35:195-203. [PMID: 32870433 DOI: 10.1007/s10557-020-07066-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
175 Jafari Khaljiri H, Jamalkhah M, Amini Harandi A, Pakdaman H, Moradi M, Mowla A. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences. Neurotox Res 2021;39:1613-29. [PMID: 34169404 DOI: 10.1007/s12640-021-00389-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Giuffrè M, Vetrugno L, Di Bella S, Moretti R, Berretti D, Crocè LS. Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature. Healthcare (Basel) 2021;9:956. [PMID: 34442092 DOI: 10.3390/healthcare9080956] [Reference Citation Analysis]
177 Feng T, Zhang Y, Sun H, Zhang H, Sun M, Wang Y, Sun C, Li K, Wang Y, Chai R, Zheng P, Chen Y, Pan P, Bi C, Yao Y, Liu S. Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China. Medicine (Baltimore) 2021;100:e26298. [PMID: 34190148 DOI: 10.1097/MD.0000000000026298] [Reference Citation Analysis]
178 Gallardo-Escárate C, Valenzuela-Muñoz V, Núñez-Acuña G, Valenzuela-Miranda D, Benaventel BP, Sáez-Vera C, Urrutia H, Novoa B, Figueras A, Roberts S, Assmann P, Bravo M. The wastewater microbiome: A novel insight for COVID-19 surveillance. Sci Total Environ 2021;764:142867. [PMID: 33071116 DOI: 10.1016/j.scitotenv.2020.142867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
179 Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F, Brown Jr RS, Carr-Locke D, Cohen DE, Sharaiha RZ. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol 2020; 26(14): 1546-1553 [PMID: 32327904 DOI: 10.3748/wjg.v26.i14.1546] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
180 Amaral LTW, Brito VM, Beraldo GL, Fonseca EKUN, Yokoo P, Talans A, Oranges Filho M, Chate RC, Baroni RH, Szarf G. Abdominal symptoms as initial manifestation of COVID-19: a case series. Einstein (Sao Paulo). 2020;18:eRC5831. [PMID: 33084795 DOI: 10.31744/einstein_journal/2020rc5831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
181 Baindara P, Chakraborty R, Holliday ZM, Mandal SM, Schrum AG. Oral probiotics in coronavirus disease 2019: connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials. New Microbes New Infect 2021;40:100837. [PMID: 33425362 DOI: 10.1016/j.nmni.2021.100837] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
182 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Al-Horani RA, Kar S, Aliter KF. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials. Int J Mol Sci 2020;21:E5224. [PMID: 32718020 DOI: 10.3390/ijms21155224] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
184 Giuffrè M, Bozzato AM, Di Bella S, Occhipinti AA, Martingano P, Cavallaro MFM, Luzzati R, Monica F, Cova MA, Crocè LS. Spontaneous Rectal Perforation in a Patient with SARS-CoV-2 Infection. J Pers Med 2020;10:E157. [PMID: 33049924 DOI: 10.3390/jpm10040157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
185 Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Response to the letter of L. Santacroce regarding article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.). Diabetes Metab Syndr 2020;14:839. [PMID: 32540739 DOI: 10.1016/j.dsx.2020.06.017] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
186 Shah MD, Sumeh AS, Sheraz M, Kavitha MS, Venmathi Maran BA, Rodrigues KF. A mini-review on the impact of COVID 19 on vital organs. Biomed Pharmacother 2021;143:112158. [PMID: 34507116 DOI: 10.1016/j.biopha.2021.112158] [Reference Citation Analysis]
187 Gao S, Lu Y, Luan J, Zhang L. Low incidence rate of diarrhoea in COVID-19 patients is due to integrin. J Infect 2021;83:496-522. [PMID: 34274362 DOI: 10.1016/j.jinf.2021.07.007] [Reference Citation Analysis]
188 Xia Y, Chen W, Ren H, Zhao J, Wang L, Jin R, Zhou J, Wang Q, Yan F, Zhang B, Lou J, Wang S, Li X, Zhou J, Xia L, Jin C, Feng J, Li W, Shen H. A rapid screening classifier for diagnosing COVID-19. Int J Biol Sci 2021;17:539-48. [PMID: 33613111 DOI: 10.7150/ijbs.53982] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
189 Ilie OD, Ciobica A, Doroftei B. Testing the Accuracy of the ARIMA Models in Forecasting the Spreading of COVID-19 and the Associated Mortality Rate. Medicina (Kaunas) 2020;56:E566. [PMID: 33121072 DOI: 10.3390/medicina56110566] [Reference Citation Analysis]